| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Research Center for Genetic Medicine, Children’s National Medical Center (Drs. Hoffbuhr, LaFleur, Sirianni, Scacheri, Giron, and Hoffman), Washington, DC; Transgenomic Inc. (Drs. Devaney and Marino), Gaithersburg, MD; Division of Pediatric Genetics, University of Michigan (Dr. Schuette), Ann Arbor; Mental Retardation Research Center, UCLA (Dr. Philippart), Los Angeles, CA; Childrens Hospital (Dr. Narayanan), Pittsburgh, PA; Child Development Center, Children’s Hospital (Dr. Umansky), Oakland, CA; New York Medical College (Dr. Kronn), New York; and Neurogenetics Unit, Kennedy Krieger Institute, Johns Hopkins University (Dr. Naidu), Baltimore, MD.
Address correspondence and reprint requests to Eric P. Hoffman, Research Center for Genetic Medicine, Children’s National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010.
Background: Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the X-linked methyl CpG binding protein 2 (MeCP2) gene. Methods: One hundred sixteen patients with classical and atypical RTT were studied for mutations of the MeCP2 gene by using DHPLC and direct sequencing. Results:Causative mutations in the MeCP2 gene were identified in 63% of patients, representing a total of 30 different mutations. Mutations were identified in 72% of patients with classical RTT and one third of atypical cases studied (8 of 25). The authors found 17 novel mutations, including a complex gene rearrangement found in one individual involving two deletions and a duplication. The duplication was identical to a region within the 3' untranslated region (UTR), and represents the first report of involvement of the 3' UTR in RTT. The authors also report the identification of MeCP2 mutations in two males; a Klinefelter’s male with classic RTT (T158M) and a hemizygous male infant with a Xq27-28 inversion and a novel 32 bp frameshift deletion [1154(del32)]. Studies examining the relationship between mutation type, X-inactivation status, and severity of clinical presentation found significant differences in clinical presentation between different types of mutations. Mutations in the amino-terminus were significantly correlated with a more severe clinical presentation compared with mutations closer to the carboxyl-terminus of MeCP2. Skewed X-inactivation patterns were found in two asymptomatic carriers of MeCP2 mutations and six girls diagnosed with either atypical or classical RTT. Conclusion:This patient series confirms the high frequency of MeCP2gene mutations causative of RTT in females and provides data concerning the molecular basis for clinical variability (mutation type and position and X-inactivation patterns).
This article has been cited by other articles:
|
|
 |
|
  A. H. Joyner, C. R. J., C. S. Bloss, T. E. Bakken, L. M. Rimol, I. Melle, I. Agartz, S. Djurovic, E. J. Topol, N. J. Schork, et al. A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations PNAS, September 8, 2009; 106(36): 15483 - 15488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Santos, T. Temudo, T. Kay, I. Carrilho, A. Medeira, H. Cabral, R. Gomes, M. T. Lourencco, M. Venancio, E. Calado, et al. Mutations in the MECP2 Gene Are Not a Major Cause of Rett Syndrome-Like or Related Neurodevelopmental Phenotype in Male Patients J Child Neurol, January 1, 2009; 24(1): 49 - 55. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Bebbington, A. Anderson, D. Ravine, S. Fyfe, M. Pineda, N. de Klerk, B. Ben-Zeev, N. Yatawara, A. Percy, W. E. Kaufmann, et al. Investigating genotype-phenotype relationships in Rett syndrome using an international data set Neurology, March 11, 2008; 70(11): 868 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Xinhua Bao, Shengling Jiang, Fuying Song, Hong Pan, Meirong Li, and X.-R. Wu X Chromosome Inactivation in Rett Syndrome and Its Correlations With MeCP2 Mutations and Phenotype J Child Neurol, January 1, 2008; 23(1): 22 - 25. [Abstract] [PDF]
|
|
|
|
 |
|
 P Huppke, E M Maier, A Warnke, C Brendel, F Laccone, and J Gartner Very mild cases of Rett syndrome with skewed X inactivation J. Med. Genet., October 1, 2006; 43(10): 814 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ventura, R. Galluzzi, S. M. Bacca, R. Giorda, and A. Massagli A novel familial MECP2 mutation in a young boy: clinical and molecular findings. Neurology, September 12, 2006; 67(5): 867 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H L Archer, S D Whatley, J C Evans, D Ravine, P Huppke, A Kerr, D Bunyan, B Kerr, E Sweeney, S J Davies, et al. Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients J. Med. Genet., May 1, 2006; 43(5): 451 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Huppke and J. Gartner Molecular Diagnosis of Rett Syndrome J Child Neurol, September 1, 2005; 20(9): 732 - 736. [Abstract] [PDF]
|
|
|
|
|
|
H. Y. Zoghbi MeCP2 Dysfunction in Humans and Mice J Child Neurol, September 1, 2005; 20(9): 736 - 740. [Abstract] [PDF]
|
|
|
|
|
|
Y. Nomura and M. Segawa Natural History of Rett Syndrome J Child Neurol, September 1, 2005; 20(9): 764 - 768. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, September 1, 2005; 20(9): 768 - 778. [Abstract] [PDF]
|
|
|
|
|
|
R. E. Amir, V. R. Sutton, and I. B. Van den Veyver Newborn Screening and Prenatal Diagnosis for Rett Syndrome: Implications for Therapy J Child Neurol, September 1, 2005; 20(9): 779 - 783. [Abstract] [PDF]
|
|
|
|
|
|
P. Huppke and J. Gartner Molecular Diagnosis of Rett Syndrome J Child Neurol, August 1, 2005; 20(8): 732 - 736. [Abstract] [PDF]
|
|
|
|
|
|
H. Y. Zoghbi MeCP2 Dysfunction in Humans and Mice J Child Neurol, August 1, 2005; 20(8): 736 - 740. [Abstract] [PDF]
|
|
|
|
|
|
Y. Nomura and M. Segawa Natural History of Rett Syndrome J Child Neurol, August 1, 2005; 20(8): 764 - 768. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, August 1, 2005; 20(8): 768 - 778. [Abstract] [PDF]
|
|
|
|
|
|
R. E. Amir, V. Reid Sutton, and I. B. Van den Veyver Newborn Screening and Prenatal Diagnosis for Rett Syndrome: Implications for Therapy J Child Neurol, August 1, 2005; 20(8): 779 - 783. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Watson, G. J. Pelka, T. Radziewic, M. D. Shahbazian, J. Christodoulou, S. L. Williamson, and P. P.L. Tam Reduced proportion of Purkinje cells expressing paternally derived mutant Mecp2308 allele in female mouse cerebellum is not due to a skewed primary pattern of X-chromosome inactivation Hum. Mol. Genet., July 1, 2005; 14(13): 1851 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Caballero and B. Hendrich MeCP2 in neurons: closing in on the causes of Rett syndrome Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R19 - R26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Moore, H. Leonard, N. de Klerk, I. Robertson, S. Fyfe, J. Christodoulou, L. Weaving, M. Davis, S. Mulroy, and L. Colvin Health Service Use in Rett Syndrome J Child Neurol, January 1, 2005; 20(1): 42 - 50. [Abstract] [PDF]
|
|
|
|
|
|
L S Weaving, C J Ellaway, J Gecz, and J Christodoulou Rett syndrome: clinical review and genetic update J. Med. Genet., January 1, 2005; 42(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Dotti, F. Guideri, M. Acampa, A. Orrico, C. Battisti, and A. Federico Autonomic Dysfunction in Mental Retardation and Spastic Paraparesis With MECP2 Mutation J Child Neurol, December 1, 2004; 19(12): 964 - 966. [Abstract] [PDF]
|
|
|
|
|
|
D. Braunschweig, T. Simcox, R. C. Samaco, and J. M. LaSalle X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain Hum. Mol. Genet., June 15, 2004; 13(12): 1275 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Kammoun, N de Roux, O Boespflug-Tanguy, L Vallee, R Seng, M Tardieu, and P Landrieu Screening of MECP2 coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases J. Med. Genet., June 1, 2004; 41(6): e85 - e85. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Neul and H. Y. Zoghbi Rett Syndrome: A Prototypical Neurodevelopmental Disorder Neuroscientist, April 1, 2004; 10(2): 118 - 128. [Abstract] [PDF]
|
|
|
|
|
|
L Colvin, H Leonard, N de Klerk, M Davis, L Weaving, S Williamson, and J Christodoulou Refining the phenotype of common mutations in Rett syndrome J. Med. Genet., January 1, 2004; 41(1): 25 - 30. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Zoghbi Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? Science, October 31, 2003; 302(5646): 826 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Naidu, G. Bibat, L. Kratz, R. I. Kelley, J. Pevsner, E. Hoffman, C. Cuffari, C. Rohde, M. E. Blue, and M. V. Johnston Clinical Variability in Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 662 - 668. [Abstract] [PDF]
|
|
|
|
|
|
J. Christodoulou and L. S. Weaving MECP2 and Beyond: Phenotype--Genotype Correlations in Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 669 - 674. [Abstract] [PDF]
|
|
|
|
|
|
S Kudo, Y Nomura, M Segawa, N Fujita, M Nakao, C Schanen, and M Tamura Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain J. Med. Genet., July 1, 2003; 40(7): 487 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Thistlethwaite, L. M. Moses, K. C. Hoffbuhr, J. M. Devaney, and E. P. Hoffman Rapid Genotyping of Common MeCP2 Mutations with an Electronic DNA Microchip Using Serial Differential Hybridization J. Mol. Diagn., May 1, 2003; 5(2): 121 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Leonard, L Colvin, J Christodoulou, T Schiavello, S Williamson, M Davis, D Ravine, S Fyfe, N de Klerk, T Matsuishi, et al. Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? J. Med. Genet., May 1, 2003; 40(5): e52 - 52. [Full Text] [PDF]
|
|
|
|
 |
|
 S A Lynch, S D Whatley, V Ramesh, S Sinha, and D Ravine Sporadic case of fatal encephalopathy with neonatal onset associated with a T158M missense mutation in MECP2 Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2003; 88(3): F250 - F252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Turner, F MacDonald, S Warburton, F Latif, and T Webb Developmental delay and the methyl binding genes J. Med. Genet., February 1, 2003; 40(2): e13 - 13. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Touitou, P. J. Shaw, J. Christodoulou, and A. Mansour Should patients with FMF undergo BMT? Blood, February 1, 2003; 101(3): 1205 - 1205. [Full Text] [PDF]
|
|
|
|
|
|
K Ravn, J B Nielsen, P Uldall, F J Hansen, and M Schwartz No correlation between phenotype and genotype in boys with a truncating MECP2 mutation J. Med. Genet., January 1, 2003; 40(1): e5 - 5. [Full Text] [PDF]
|
|
|
|
 |
|
 L Colvin, S Fyfe, S Leonard, T Schiavello, C Ellaway, N de Klerk, J Christodoulou, M Msall, and H Leonard Describing the phenotype in Rett syndrome using a population database Arch. Dis. Child., January 1, 2003; 88(1): 38 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-F. Wu, A. Ryan, J. Devaney, M. Warnstedt, Z. Korade-Mirnics, B. Poser, M. J. Escriva, E. Pegoraro, A. S. Yee, K. J. Felice, et al. Novel CLCN1 mutations with unique clinical and electrophysiological consequences Brain, November 1, 2002; 125(11): 2392 - 2407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Laccone, B Zoll, P Huppke, F Hanefeld, W Pepinski, and R Trappe MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution J. Med. Genet., August 1, 2002; 39(8): 586 - 588. [Full Text] [PDF]
|
|
|
|
 |
|
 P Nokelainen and J Flint Genetic effects on human cognition: lessons from the study of mental retardation syndromes J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 287 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Jong Hee Chae, Yong Seung Hwang, and Ki Joong Kim Mutation Analysis of MECP2 and Clinical Characterization in Korean Patients With Rett Syndrome J Child Neurol, January 1, 2002; 17(1): 33 - 36. [Abstract] [PDF]
|
|
|
|
|
|
B. Hendrich and W. Bickmore Human diseases with underlying defects in chromatin structure and modification Hum. Mol. Genet., October 1, 2001; 10(20): 2233 - 2242. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
